Tokai Pharmaceuticals, Inc.

Jodie Pope Morrison

David S Casebier

Cy Aaron Stein

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.

Treatment of prostate cancer

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. Such compounds include inhibitors of cytochrome C17-hydroxylase/C-lyase such as 3-&#x3b2;-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene.

Growing community of inventors

Wakefield, MA, United States of America

Jodie Pope Morrison